BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2017
View Archived Issues
Medlab receives ethics approvals for trials of two cannabis-based medicines
Read More
Pfizer initiates phase I study of group B Streptococcus vaccine PF-06760805
Read More
Unum Therapeutics announces active IND for ACTR-707
Read More
NIAID grants support development of vaccines for Zika virus and river blindness
Read More
Biocad's BCD-055 demonstrates equivalence to infliximab in clinical trials
Read More
twoXAR's TXR-411 shows promise in mouse model of type 2 diabetes
Read More
Phase Ib results for infigratinib plus imatinib in patients with advanced GIST presented
Read More
Phase I/II results for cabiralizumab monotherapy in patients with tenosynovial giant cell tumor
Read More
Enrollment to begin in phase I/II trial of Ceplene for the treatment of CMML
Read More
Heidelberg Pharma and Takeda sign exclusive multitarget research agreement
Read More
Phase II results show beneficial effects of NT-501 in patients with macular telangiectasia type 2
Read More
Phase II study of glepaglutide in patients with short bowel syndrome meets primary endpoint
Read More
AbbVie's lutikizumab fails primary endpoint in a phase IIa trial for hand OA
Read More
SerImmune enters research and development collaboration with Merck & Co.
Read More
NCATS grants to fund use of Emulate's Human Emulation System on International Space Station
Read More
FDA approves Mydayis for adolescents and adults with ADHD
Read More
eFFECTOR enters collaboration to study EFT-508 with avelumab in colorectal cancer
Read More
Almac Discovery collaborates with Debiopharm on Wee-1 kinase inhibitor program
Read More
NINDS grant supports development of BlackThorn Therapeutics' KOR antagonist program
Read More
Nimbus Apollo presents acetyl-CoA carboxylase inhibitors
Read More
Icagen partners with Omdana on disorders related to tissue homeostasis and vascular remodeling
Read More
Shenzhen Targetrx Biotechnology discloses novel tyrosine kinase inhibitors
Read More
Seattle Genetics submits supplemental BLA for Adcetris in CTCL
Read More
Glenmark licenses small-molecule oncology compound from APC Therapeutics
Read More
A novel orally active ACC2-selective inhibitor improves glucose homeostasis
Read More